HCP, Inc. (HCP)
Health Care Property Investors, Inc. is a real estate investment trust. The company invests in health care related real estate located throughout the United States, including long-term care facilities, congregate care and assisted living facilities, acute care and rehabilitation hospitals, medical office buildings, physician group practice clinics and psychiatric facilities.
HCP, Inc. (HCP)‘s Financial Overview
HCP, Inc. (HCP) surged 2.63% yesterday to close its trading session at $23.39. The company has 1 year Price Target of $25.5. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 5.59 Million shares yesterday. The firm shows the market capitalization of $11.14 Billion.
The firm is trading with SMA20 of 3.6 Percent, SMA50 of SMA50 Percent and SMA200 of -13.75 percent. HCP, Inc. has P/S value of 6.03 while its P/B value stands at 2.07. Similarly, the company has Return on Assets of 2.9 percent, Return on Equity of 7.4 percent and Return on Investment of 2.6 Percent. The company shows Gross Margin and Operating Margin of 64 percent and 17.9 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 2.7 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 17 analysts offering 12-month price forecasts for HCP Inc have a median target of 28.00, with a high estimate of 33.00 and a low estimate of 25.00. The median estimate represents a +19.71% increase from the last price of 23.39.
Express Scripts Holding Company (ESRX)
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Express Scripts Holding Company (ESRX)‘s Financial Outlook
The 18 analysts offering 12-month price forecasts for Express Scripts Holding Co have a median target of 80.50, with a high estimate of 98.00 and a low estimate of 65.00. The median estimate represents a +15.45% increase from the last price of 69.73.
According to Zacks Investment Research, Express Scripts Holding Company has a Consensus Recommendation of 2.52. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock declined-0.91% and closed its last trading session at $69.73. The company has the market capitalization of $39.53 Billion. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 5.57 Million shares. The company has a total of 566.84 Million shares outstanding.
Express Scripts Holding Company (ESRX) in the last quarter reported its actual EPS of $2.16/share where the analyst estimated EPS was $2.09/share. The difference between the actual and Estimated EPS is $0.07. This shows a surprise factor of 3.3 percent.
The company has YTD performance of -6.58 percent. Beta for Express Scripts Holding Company stands at 0.97 while its ATR (average true range) is 2.19. The company has Weekly Volatility of 2.72%% and Monthly Volatility of 2.92%.
Express Scripts Holding Company has distance from 20-day Simple Moving Average (SMA20) of -6.5%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of 3.93%.
The Company currently has ROA (Return on Assets) of 8.7 percent, Return on Equity (ROE) of 27.5 Percent and Return on Investment (ROI) of 19% with Gross margin of 8.8 percent and Operating & Profit margin of 5.5% and 4.5% respectively.